HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$683M |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$186M |
| 3 |
iShares Russell 1000 ETF
IWB
|
+$185M |
| 4 |
Charter Communications
CHTR
|
+$177M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONC
BeOne Medicines Ltd
ONC
|
+$348M |
| 2 |
Microsoft
MSFT
|
+$244M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$217M |
| 4 |
Johnson & Johnson
JNJ
|
+$213M |
| 5 |
Amazon
AMZN
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 12.48% |
| 2 | Technology | 11.34% |
| 3 | Financials | 8.45% |
| 4 | Communication Services | 6.87% |
| 5 | Healthcare | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Cavco Industries
CVCO
$4.54B
| $361K | ﹤0.01% |
2,769
+254
| +10% | +$45.9K |
|
2227
Saia
SAIA
$10.9B
| $361K | ﹤0.01% |
6,464
-6,419
| -50% | -$390K |
|
2228
HUTCHMED
HCM
$1.93B
| $356K | ﹤0.01% |
+15,424
| New | +$479K |
|
|
FNSR
2229
DELISTED
Finisar Corp
FNSR
| $356K | ﹤0.01% |
16,478
-1,769
| -10% | -$35.2K |
|
2230
CALL
Cleveland-Cliffs
CLF
$6.84B
| $355K | ﹤0.01% |
46,200
| – | – |
|
|
2231
PUT
Cleveland-Cliffs
CLF
$6.84B
| $355K | ﹤0.01% |
46,200
| – | – |
|
2232
Urban Edge Properties
UE
$2.92B
| $355K | ﹤0.01% |
21,311
+840
| +4% | +$16.6K |
|
2233
Grupo Aeroportuario del Sureste
ASR
$8.14B
| $354K | ﹤0.01% |
2,354
+1,308
| +125% | +$212K |
|
2234
Rexford Industrial Realty
REXR
$8.64B
| $354K | ﹤0.01% |
12,014
+1,882
| +19% | +$59.6K |
|
2235
Artisan Partners
APAM
$2.9B
| $353K | ﹤0.01% |
15,936
+2,761
| +21% | +$73.6K |
|
2236
CALL
Nutrien
NTR
$33.3B
| $353K | ﹤0.01% |
+7,500
| New | +$391K |
|
2237
Starwood Property Trust
STWD
$6.18B
| $353K | ﹤0.01% |
17,945
-6,286
| -26% | -$136K |
|
2238
PUT
Viatris
VTRS
$20.8B
| $353K | ﹤0.01% |
12,900
| – | – |
|
|
XHR
2239
Xenia Hotels & Resorts
XHR
$2.01B
| $353K | ﹤0.01% |
20,497
+2,154
| +12% | +$43.8K |
|
2240
Hanover Insurance
THG
$7.84B
| $352K | ﹤0.01% |
3,020
-109,021
| -97% | -$12.2M |
|
2241
Amneal Pharmaceuticals
AMRX
$5.99B
| $350K | ﹤0.01% |
25,937
-2,676
| -9% | -$48.2K |
|
|
KYNB
2242
Kyntra Bio
KYNB
$28.2M
| $350K | ﹤0.01% |
302
+108
| +56% | +$121K |
|
2243
Werner Enterprises
WERN
$2.3B
| $350K | ﹤0.01% |
11,832
-32,452
| -73% | -$1.06M |
|
|
INN
2244
Summit Hotel Properties
INN
$743M
| $349K | ﹤0.01% |
35,887
+2,018
| +6% | +$22.9K |
|
2245
Darling Ingredients
DAR
$9.28B
| $346K | ﹤0.01% |
18,016
+1,505
| +9% | +$30.5K |
|
2246
Avient
AVNT
$3.41B
| $345K | ﹤0.01% |
12,061
+2,806
| +30% | +$93.9K |
|
|
TCO
2247
DELISTED
Taubman Centers Inc.
TCO
| $345K | ﹤0.01% |
7,571
-794
| -9% | -$41.7K |
|
|
KSU
2248
CALL
DELISTED
Kansas City Southern
KSU
| $344K | ﹤0.01% |
3,600
| – | – |
|
2249
PUT
Cameco
CCJ
$37.9B
| $341K | ﹤0.01% |
+30,000
| New | +$347K |
|
|
CVSA
2250
Covista Inc
CVSA
$4.3B
| $339K | ﹤0.01% |
7,172
-593
| -8% | -$30.3K |
|
Similar funds
HSBC Holdings's Q4 2018 Portfolio in Review
As of Q4 2018, HSBC Holdings held 2,820 positions worth $54.1B, down 13% from $62.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
HSBC Holdings's Q4 2018 filing shows 296 new, 1,214 increased, 887 reduced and 209 closed positions. Its largest new stake was Linde: 4,324,491 shares worth $675M. The largest sale was BeOne Medicines Ltd, an estimated $348M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- HSBC Holdings's largest Q4 2018 buy was Linde: 4,324,491 shares worth $675M.
- HSBC Holdings added most to iShares JPMorgan USD Emerging Markets Bond ETF in Q4 2018, an estimated $186M increase.
- HSBC Holdings's biggest Q4 2018 reduction was BeOne Medicines Ltd, cutting an estimated $348M.
- HSBC Holdings fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $122M.
- HSBC Holdings's ten largest holdings make up 18% of its $54.1B portfolio in Q4 2018.
- HSBC Holdings opened 296 new positions and closed 209 in Q4 2018.
- HSBC Holdings's portfolio value fell 13% quarter-over-quarter to $54.1B.
Based on HSBC Holdings's 13F filing for Q4 2018, filed 13 Feb 2019.